4 Oversold Stocks That Could Take Off!

Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) and these three other stocks have seen big drops in price recently, and it could be a great opportunity for investors to lock in some great bargains.

win
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

On the TSX, where we’ve seen lots of fluctuations this year, buying when stocks are overbought and at their peak could result in losses that otherwise should have yielded you decent returns. Some people may tell you that timing a stock is not a useful strategy and that it doesn’t pay off, but doing so effectively could help you maximize your returns.

One indicator I use when evaluating whether a stock is overbought or oversold is the Relative Strength Index (RSI), which tracks average stock gains and losses, typically over the past 14 days. When the RSI level is less than 30, that is an indicator that the shares are oversold and could be due for a reversal.

I have a list of four stocks below that meet these criteria and that could be great buys today.

Barrick Gold Corp. (TSX:ABX)(NYSE:ABX) saw its share price drop 7% last week, as the company’s earnings failed to impress investors and sent the stock to under $20 a share and near its 52-week low. Year to date, the share price has lost 12% of its value, and the stock’s RSI level was 28 at the end of October 27, suggesting it may have reached a bottom.

The share price has generally found strong support at $20 for much of the year, so we could see the stock recover to those levels, at least in the short term. The company still presents strong growth prospects, and the small $11 million loss the company posted recently should not make investors forget that over the previous three quarters, Barrick has accumulated profits totaling more than $2.1 billion.

It was a disappointing quarter, but it hardly makes the stock a bad investment, especially as gold prices continue to rise.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen its share price drop 14% last month, and the stock’s RSI level currently sits just above 27. Although this is not a stock that I’m a fan of, it has seen support at $15 a share for most of the year, and in the short term, investors could be able to make some gains off of it, especially if the company can put together a strong quarter.

Corus Entertainment Inc. (TSX:CJR.B) has also underwhelmed investors with its latest earnings report, and the stock declined 10% in the past month. As a result of the decline, the already high-yielding dividend stock is now paying investors almost 10% a year. Although the dividend may seem high, it’s not a payout that I believe is in any imminent danger.

At an RSI level of just 13, the stock is heavily oversold, and it is near its 52-week low. It could be a great investment that provides you with an excellent dividend along with prospects for strong capital appreciation.

Aritzia Inc. (TSX:ATZ) recently reached its one-year mark on the TSX, and, unfortunately, since inception, the stock has dropped 34% in value. Last month, the share price declined by over 24%, as investors were unimpressed with the company’s recent earnings, which showed that sales growth was starting to slow down.

The stock is coming off a new all-time low, and with an RSI level of 26, it has actually improved from earlier in the month, when the RSI level dipped below 20.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »